newsfilter
← Latest News
GlobeNewswire·

GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease Day

SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will participate in a virtual fireside chat at the Guggenheim Genomic Medicines & Rare Disease Day on Friday, Ap